

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 8.12372757 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 7.92850215 |
| 3 | biotin metabolic process (GO:0006768) | 7.75903025 |
| 4 | low-density lipoprotein particle clearance (GO:0034383) | 7.37028174 |
| 5 | brown fat cell differentiation (GO:0050873) | 7.23918099 |
| 6 | triglyceride catabolic process (GO:0019433) | 6.97892656 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 6.68839158 |
| 8 | fatty acid beta-oxidation (GO:0006635) | 6.68497338 |
| 9 | white fat cell differentiation (GO:0050872) | 6.52228041 |
| 10 | carnitine transmembrane transport (GO:1902603) | 6.46119728 |
| 11 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 6.43665294 |
| 12 | regulation of fatty acid oxidation (GO:0046320) | 6.35594858 |
| 13 | positive regulation of fatty acid oxidation (GO:0046321) | 6.33871187 |
| 14 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.29404177 |
| 15 | acylglycerol catabolic process (GO:0046464) | 6.25508820 |
| 16 | neutral lipid catabolic process (GO:0046461) | 6.25508820 |
| 17 | NADH metabolic process (GO:0006734) | 6.23713332 |
| 18 | valine metabolic process (GO:0006573) | 6.21102379 |
| 19 | amino-acid betaine transport (GO:0015838) | 5.90523209 |
| 20 | carnitine transport (GO:0015879) | 5.90523209 |
| 21 | lipid particle organization (GO:0034389) | 5.87359446 |
| 22 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.83370567 |
| 23 | fatty acid oxidation (GO:0019395) | 5.61031374 |
| 24 | behavioral response to nicotine (GO:0035095) | 5.60653443 |
| 25 | lipid oxidation (GO:0034440) | 5.52634376 |
| 26 | fatty acid catabolic process (GO:0009062) | 5.52268775 |
| 27 | lipid storage (GO:0019915) | 5.45882587 |
| 28 | regulation of cofactor metabolic process (GO:0051193) | 5.39984176 |
| 29 | regulation of coenzyme metabolic process (GO:0051196) | 5.39984176 |
| 30 | regulation of cholesterol storage (GO:0010885) | 5.34530256 |
| 31 | branched-chain amino acid catabolic process (GO:0009083) | 5.24285982 |
| 32 | triglyceride biosynthetic process (GO:0019432) | 5.16071881 |
| 33 | thioester biosynthetic process (GO:0035384) | 4.96304252 |
| 34 | acyl-CoA biosynthetic process (GO:0071616) | 4.96304252 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 4.95172898 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 4.93871799 |
| 37 | neutral lipid biosynthetic process (GO:0046460) | 4.91723186 |
| 38 | acylglycerol biosynthetic process (GO:0046463) | 4.91723186 |
| 39 | regulation of skeletal muscle contraction (GO:0014819) | 4.79283589 |
| 40 | positive regulation of lipid storage (GO:0010884) | 4.77121355 |
| 41 | muscle filament sliding (GO:0030049) | 4.76538638 |
| 42 | actin-myosin filament sliding (GO:0033275) | 4.76538638 |
| 43 | intracellular lipid transport (GO:0032365) | 4.75678476 |
| 44 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.69599710 |
| 45 | tricarboxylic acid metabolic process (GO:0072350) | 4.60642379 |
| 46 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.58153836 |
| 47 | glycerolipid catabolic process (GO:0046503) | 4.58082226 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.47125763 |
| 49 | coenzyme A biosynthetic process (GO:0015937) | 4.45922420 |
| 50 | succinate metabolic process (GO:0006105) | 4.44178324 |
| 51 | positive regulation of lipid catabolic process (GO:0050996) | 4.40769288 |
| 52 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.40592363 |
| 53 | quaternary ammonium group transport (GO:0015697) | 4.31557802 |
| 54 | regulation of sulfur metabolic process (GO:0042762) | 4.25738788 |
| 55 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.23547402 |
| 56 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.21745136 |
| 57 | monocarboxylic acid catabolic process (GO:0072329) | 4.17776089 |
| 58 | negative regulation of lipid storage (GO:0010888) | 4.10516339 |
| 59 | kynurenine metabolic process (GO:0070189) | 4.02431581 |
| 60 | regulation of relaxation of muscle (GO:1901077) | 3.95899729 |
| 61 | actin-mediated cell contraction (GO:0070252) | 3.95006719 |
| 62 | triglyceride metabolic process (GO:0006641) | 3.93284307 |
| 63 | regulation of lipid storage (GO:0010883) | 3.89318351 |
| 64 | DNA deamination (GO:0045006) | 3.88588826 |
| 65 | ubiquinone biosynthetic process (GO:0006744) | 3.86736620 |
| 66 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.84915753 |
| 67 | regulation of glucokinase activity (GO:0033131) | 3.82369922 |
| 68 | regulation of hexokinase activity (GO:1903299) | 3.82369922 |
| 69 | carnitine metabolic process (GO:0009437) | 3.79912414 |
| 70 | L-fucose catabolic process (GO:0042355) | 3.79509487 |
| 71 | fucose catabolic process (GO:0019317) | 3.79509487 |
| 72 | L-fucose metabolic process (GO:0042354) | 3.79509487 |
| 73 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.78696746 |
| 74 | cardiolipin metabolic process (GO:0032048) | 3.78099905 |
| 75 | skeletal muscle contraction (GO:0003009) | 3.77951716 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.77301685 |
| 77 | long-chain fatty acid transport (GO:0015909) | 3.75441541 |
| 78 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.70648330 |
| 79 | acylglycerol metabolic process (GO:0006639) | 3.69168354 |
| 80 | cellular ketone body metabolic process (GO:0046950) | 3.65893426 |
| 81 | neutral lipid metabolic process (GO:0006638) | 3.63509082 |
| 82 | coenzyme A metabolic process (GO:0015936) | 3.59382478 |
| 83 | ubiquinone metabolic process (GO:0006743) | 3.55779848 |
| 84 | cellular lipid catabolic process (GO:0044242) | 3.54971013 |
| 85 | lysine catabolic process (GO:0006554) | 3.51491079 |
| 86 | lysine metabolic process (GO:0006553) | 3.51491079 |
| 87 | NADPH regeneration (GO:0006740) | 3.50435240 |
| 88 | pentose-phosphate shunt (GO:0006098) | 3.48633758 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 3.48103164 |
| 90 | ovulation from ovarian follicle (GO:0001542) | 3.45688060 |
| 91 | regulation of fatty acid metabolic process (GO:0019217) | 3.45417798 |
| 92 | cytidine deamination (GO:0009972) | 3.43504772 |
| 93 | cytidine metabolic process (GO:0046087) | 3.43504772 |
| 94 | cytidine catabolic process (GO:0006216) | 3.43504772 |
| 95 | indole-containing compound catabolic process (GO:0042436) | 3.43101668 |
| 96 | indolalkylamine catabolic process (GO:0046218) | 3.43101668 |
| 97 | tryptophan catabolic process (GO:0006569) | 3.43101668 |
| 98 | acyl-CoA metabolic process (GO:0006637) | 3.43005314 |
| 99 | thioester metabolic process (GO:0035383) | 3.43005314 |
| 100 | alpha-linolenic acid metabolic process (GO:0036109) | 3.41084917 |
| 101 | fatty acid homeostasis (GO:0055089) | 3.38855408 |
| 102 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.37573900 |
| 103 | plasma lipoprotein particle clearance (GO:0034381) | 3.36491642 |
| 104 | cellular response to lithium ion (GO:0071285) | 3.35459320 |
| 105 | glycerol metabolic process (GO:0006071) | 3.32612288 |
| 106 | regulation of triglyceride metabolic process (GO:0090207) | 3.31804877 |
| 107 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.31747670 |
| 108 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.28820675 |
| 109 | ketone body metabolic process (GO:1902224) | 3.23574017 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 3.23070624 |
| 111 | indolalkylamine metabolic process (GO:0006586) | 3.23046305 |
| 112 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.20701996 |
| 113 | cellular response to zinc ion (GO:0071294) | 3.17850860 |
| 114 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.14114471 |
| 115 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.13054566 |
| 116 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.11969693 |
| 117 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.11713001 |
| 118 | NADH dehydrogenase complex assembly (GO:0010257) | 3.11713001 |
| 119 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.11713001 |
| 120 | fatty acid transport (GO:0015908) | 3.11110231 |
| 121 | synaptic transmission, cholinergic (GO:0007271) | 3.11105492 |
| 122 | regulation of lipid catabolic process (GO:0050994) | 3.10164856 |
| 123 | phosphatidic acid biosynthetic process (GO:0006654) | 3.09234602 |
| 124 | phosphatidic acid metabolic process (GO:0046473) | 3.09234602 |
| 125 | neuronal action potential propagation (GO:0019227) | 3.05799304 |
| 126 | quinone biosynthetic process (GO:1901663) | 3.05018223 |
| 127 | response to pheromone (GO:0019236) | 3.03608871 |
| 128 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02510755 |
| 129 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01709048 |
| 130 | response to cold (GO:0009409) | 3.00879973 |
| 131 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.00692658 |
| 132 | neuromuscular synaptic transmission (GO:0007274) | 2.99080487 |
| 133 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.98974944 |
| 134 | cellular response to ATP (GO:0071318) | 2.98890084 |
| 135 | neuronal action potential (GO:0019228) | 2.98380287 |
| 136 | response to dietary excess (GO:0002021) | 2.98238790 |
| 137 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.97679334 |
| 138 | negative regulation of protein autophosphorylation (GO:0031953) | 2.95440867 |
| 139 | piRNA metabolic process (GO:0034587) | 2.95312559 |
| 140 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.95212260 |
| 141 | positive regulation of glycolytic process (GO:0045821) | 2.95171312 |
| 142 | protein heterotrimerization (GO:0070208) | 2.95099639 |
| 143 | auditory receptor cell stereocilium organization (GO:0060088) | 2.94709588 |
| 144 | protein complex biogenesis (GO:0070271) | 2.94520785 |
| 145 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.94445198 |
| 146 | platelet dense granule organization (GO:0060155) | 2.94402573 |
| 147 | response to inactivity (GO:0014854) | 2.93992885 |
| 148 | myotube cell development (GO:0014904) | 2.90086621 |
| 149 | response to muscle activity (GO:0014850) | 2.89540717 |
| 150 | tryptophan metabolic process (GO:0006568) | 2.87601988 |
| 151 | protein polyglutamylation (GO:0018095) | 2.86953122 |
| 152 | gamma-aminobutyric acid transport (GO:0015812) | 2.82393744 |
| 153 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.81092652 |
| 154 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.80647716 |
| 155 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79571781 |
| 156 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79571781 |
| 157 | negative regulation of telomere maintenance (GO:0032205) | 2.78668160 |
| 158 | skeletal muscle fiber development (GO:0048741) | 2.78593434 |
| 159 | respiratory chain complex IV assembly (GO:0008535) | 2.76637229 |
| 160 | regulation of action potential (GO:0098900) | 2.76097697 |
| 161 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.73417242 |
| 162 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.72933333 |
| 163 | dopamine transport (GO:0015872) | 2.71642924 |
| 164 | sulfation (GO:0051923) | 2.71381486 |
| 165 | membrane depolarization during action potential (GO:0086010) | 2.70741882 |
| 166 | striated muscle contraction (GO:0006941) | 2.69459112 |
| 167 | cAMP catabolic process (GO:0006198) | 2.68402912 |
| 168 | myofibril assembly (GO:0030239) | 2.68162574 |
| 169 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.67809340 |
| 170 | positive regulation of mitochondrial fission (GO:0090141) | 2.63420687 |
| 171 | indole-containing compound metabolic process (GO:0042430) | 2.63218219 |
| 172 | regulation of cell communication by electrical coupling (GO:0010649) | 2.59803240 |
| 173 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.58744361 |
| 174 | axoneme assembly (GO:0035082) | 2.57082083 |
| 175 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.54389501 |
| 176 | electron transport chain (GO:0022900) | 2.54181227 |
| 177 | reflex (GO:0060004) | 2.53865914 |
| 178 | somite development (GO:0061053) | 2.53769681 |
| 179 | muscle fiber development (GO:0048747) | 2.53059511 |
| 180 | mannosylation (GO:0097502) | 2.52180586 |
| 181 | protein-cofactor linkage (GO:0018065) | 2.52016748 |
| 182 | neural tube formation (GO:0001841) | 2.51025565 |
| 183 | inositol phosphate catabolic process (GO:0071545) | 2.50957947 |
| 184 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.50820572 |
| 185 | male meiosis I (GO:0007141) | 2.48796437 |
| 186 | protein K11-linked deubiquitination (GO:0035871) | 2.47244168 |
| 187 | respiratory electron transport chain (GO:0022904) | 2.46545975 |
| 188 | primary amino compound metabolic process (GO:1901160) | 2.45663135 |
| 189 | skeletal muscle adaptation (GO:0043501) | 2.45148041 |
| 190 | sarcomere organization (GO:0045214) | 2.42379910 |
| 191 | cyclic nucleotide catabolic process (GO:0009214) | 2.41927236 |
| 192 | creatine metabolic process (GO:0006600) | 2.40243335 |
| 193 | inner ear receptor stereocilium organization (GO:0060122) | 2.39001875 |
| 194 | DNA methylation involved in gamete generation (GO:0043046) | 2.38036068 |
| 195 | action potential (GO:0001508) | 2.37857149 |
| 196 | plasma membrane repair (GO:0001778) | 2.37648539 |
| 197 | regulation of sequestering of triglyceride (GO:0010889) | 10.4538162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 7.40887511 |
| 2 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.07170897 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.71714116 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.41441259 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.36568311 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.07700820 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.00450037 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92151989 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.85451829 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68646938 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.61753069 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.54284475 |
| 13 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49745054 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.46956224 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44216726 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.31229403 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24749940 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.23627129 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.21595531 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.15552483 |
| 21 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.14681225 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13609208 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.10863406 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.06803852 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02946383 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 15.6994681 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99127612 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.95026836 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.94974844 |
| 30 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.94001857 |
| 31 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.91912050 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87345362 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.86197637 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83364368 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80928022 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.80239440 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80039056 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.79979614 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72656501 |
| 40 | EWS_26573619_Chip-Seq_HEK293_Human | 1.71734482 |
| 41 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.71573003 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69350587 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68901063 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.67524474 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65214847 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62957728 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.57743234 |
| 48 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57246748 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56657367 |
| 50 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56657367 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.54573771 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.54573771 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54223229 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48269830 |
| 55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47638337 |
| 56 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47626532 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46797806 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45728470 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43141913 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.42895107 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41490604 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41392231 |
| 63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.39846692 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39582023 |
| 65 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.38669778 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38044219 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37906475 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37786006 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37374891 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37314888 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36640484 |
| 72 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36628225 |
| 73 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36628225 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34209162 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34033836 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33063479 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32862057 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.32591196 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32340374 |
| 80 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32175768 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31950785 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31392142 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30501487 |
| 84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30426513 |
| 85 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30350140 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29336792 |
| 87 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29127701 |
| 88 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27503409 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24440329 |
| 90 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23867053 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23255079 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21930198 |
| 93 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20792633 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20743728 |
| 95 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19258407 |
| 96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19069002 |
| 97 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19069002 |
| 98 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17688798 |
| 99 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.17129935 |
| 100 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16320706 |
| 101 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.15284520 |
| 102 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15212974 |
| 103 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15181865 |
| 104 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13356059 |
| 105 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12799874 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.12698440 |
| 107 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.11951904 |
| 108 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11420231 |
| 109 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11206721 |
| 110 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10586228 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10348606 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08849592 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 1.08310919 |
| 114 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07830734 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07830281 |
| 116 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07431777 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06234097 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05081425 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04917489 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04624416 |
| 121 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04242386 |
| 122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04090058 |
| 123 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02862054 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02670111 |
| 125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02571081 |
| 126 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01738573 |
| 127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00846346 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00555509 |
| 129 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00305021 |
| 130 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99694639 |
| 131 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99579813 |
| 132 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99472765 |
| 133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98663054 |
| 134 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98663054 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98138902 |
| 136 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.97755951 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97150573 |
| 138 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97024639 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96759037 |
| 140 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.96626023 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95958025 |
| 142 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95193442 |
| 143 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94588055 |
| 144 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94251752 |
| 145 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91452841 |
| 146 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91302196 |
| 147 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91186934 |
| 148 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89896330 |
| 149 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88837552 |
| 150 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88219595 |
| 151 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88061632 |
| 152 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87714507 |
| 153 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87014718 |
| 154 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.84593688 |
| 155 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84340829 |
| 156 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83691896 |
| 157 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82655244 |
| 158 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.82322768 |
| 159 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81983068 |
| 160 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78811847 |
| 161 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.78495755 |
| 162 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.78243260 |
| 163 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.76975859 |
| 164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76762629 |
| 165 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75523371 |
| 166 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75523371 |
| 167 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75507736 |
| 168 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75087631 |
| 169 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.72224538 |
| 170 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70469412 |
| 171 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.68120382 |
| 172 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.67915579 |
| 173 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67808802 |
| 174 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65471951 |
| 175 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.64538758 |
| 176 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.64034594 |
| 177 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63126157 |
| 178 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61102435 |
| 179 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.61009931 |
| 180 | SPI1_23127762_ChIP-Seq_K562_Human | 0.59650922 |
| 181 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.59403802 |
| 182 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59336169 |
| 183 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.59014932 |
| 184 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.58346083 |
| 185 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57856332 |
| 186 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57656546 |
| 187 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.56804463 |
| 188 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55596767 |
| 189 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55074615 |
| 190 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.54607763 |
| 191 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51581560 |
| 192 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.51497917 |
| 193 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.51222430 |
| 194 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.50297771 |
| 195 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50067639 |
| 196 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49159596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.88652745 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.62140026 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 5.35642355 |
| 4 | MP0004130_abnormal_muscle_cell | 5.14636477 |
| 5 | MP0004185_abnormal_adipocyte_glucose | 4.94763036 |
| 6 | MP0005375_adipose_tissue_phenotype | 3.89685521 |
| 7 | MP0002971_abnormal_brown_adipose | 3.74228760 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.63319110 |
| 9 | MP0008438_abnormal_cutaneous_collagen | 3.24648068 |
| 10 | MP0003646_muscle_fatigue | 3.13511846 |
| 11 | MP0009115_abnormal_fat_cell | 2.60240681 |
| 12 | MP0000003_abnormal_adipose_tissue | 2.54690196 |
| 13 | MP0003195_calcinosis | 2.54050933 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.49454138 |
| 15 | MP0005535_abnormal_body_temperature | 2.39442491 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.38831878 |
| 17 | MP0005334_abnormal_fat_pad | 2.25020885 |
| 18 | MP0002970_abnormal_white_adipose | 2.22036065 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.20067932 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 2.11952489 |
| 21 | MP0002102_abnormal_ear_morphology | 2.03059636 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.02212055 |
| 23 | MP0005275_abnormal_skin_tensile | 2.00123092 |
| 24 | MP0004043_abnormal_pH_regulation | 1.99081795 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.92830097 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.91269863 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.90247061 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.84992282 |
| 29 | MP0004142_abnormal_muscle_tone | 1.83178658 |
| 30 | MP0003724_increased_susceptibility_to | 1.78529368 |
| 31 | MP0008775_abnormal_heart_ventricle | 1.77536472 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.74082485 |
| 33 | MP0008872_abnormal_physiological_respon | 1.68092286 |
| 34 | MP0005330_cardiomyopathy | 1.67345599 |
| 35 | MP0006138_congestive_heart_failure | 1.60297974 |
| 36 | MP0000751_myopathy | 1.59284328 |
| 37 | MP0000343_altered_response_to | 1.58601324 |
| 38 | MP0009046_muscle_twitch | 1.58010059 |
| 39 | MP0005448_abnormal_energy_balance | 1.54256310 |
| 40 | MP0004272_abnormal_basement_membrane | 1.52009689 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.51869211 |
| 42 | MP0005385_cardiovascular_system_phenoty | 1.50517532 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.50517532 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.48681910 |
| 45 | MP0005253_abnormal_eye_physiology | 1.48463909 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.48140947 |
| 47 | MP0001661_extended_life_span | 1.43475255 |
| 48 | MP0003011_delayed_dark_adaptation | 1.43370855 |
| 49 | MP0008875_abnormal_xenobiotic_pharmacok | 1.42248781 |
| 50 | MP0004087_abnormal_muscle_fiber | 1.41930792 |
| 51 | MP0009745_abnormal_behavioral_response | 1.41896112 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 1.41788163 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.40973898 |
| 54 | MP0003186_abnormal_redox_activity | 1.39869088 |
| 55 | MP0002272_abnormal_nervous_system | 1.39361933 |
| 56 | MP0003828_pulmonary_edema | 1.39332542 |
| 57 | MP0000747_muscle_weakness | 1.38241279 |
| 58 | MP0003959_abnormal_lean_body | 1.37412295 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.36595696 |
| 60 | MP0003880_abnormal_central_pattern | 1.34729973 |
| 61 | MP0005452_abnormal_adipose_tissue | 1.33826895 |
| 62 | MP0003690_abnormal_glial_cell | 1.31509335 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.30685116 |
| 64 | MP0000609_abnormal_liver_physiology | 1.29588570 |
| 65 | MP0002972_abnormal_cardiac_muscle | 1.25645886 |
| 66 | MP0001485_abnormal_pinna_reflex | 1.25135273 |
| 67 | MP0004084_abnormal_cardiac_muscle | 1.24712255 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 1.24632320 |
| 69 | MP0004885_abnormal_endolymph | 1.24083062 |
| 70 | MP0002736_abnormal_nociception_after | 1.23580701 |
| 71 | MP0001984_abnormal_olfaction | 1.22643313 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 1.21117758 |
| 73 | MP0005620_abnormal_muscle_contractility | 1.20380977 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.19901272 |
| 75 | MP0000750_abnormal_muscle_regeneration | 1.17628946 |
| 76 | MP0000749_muscle_degeneration | 1.14224968 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14035015 |
| 78 | MP0000427_abnormal_hair_cycle | 1.11712880 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.11586877 |
| 80 | MP0003705_abnormal_hypodermis_morpholog | 1.09787590 |
| 81 | MP0004270_analgesia | 1.09674123 |
| 82 | MP0010630_abnormal_cardiac_muscle | 1.08442325 |
| 83 | MP0004036_abnormal_muscle_relaxation | 1.03927153 |
| 84 | MP0005332_abnormal_amino_acid | 1.03319003 |
| 85 | MP0001486_abnormal_startle_reflex | 1.02036383 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.01371587 |
| 87 | MP0004133_heterotaxia | 1.00184720 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.99124825 |
| 89 | MP0002166_altered_tumor_susceptibility | 0.97889905 |
| 90 | MP0000759_abnormal_skeletal_muscle | 0.97387034 |
| 91 | MP0002064_seizures | 0.97264594 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.96684718 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.96436919 |
| 94 | MP0002734_abnormal_mechanical_nocicepti | 0.95954474 |
| 95 | MP0001853_heart_inflammation | 0.95388607 |
| 96 | MP0003136_yellow_coat_color | 0.94745260 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.93536388 |
| 98 | MP0002733_abnormal_thermal_nociception | 0.93150021 |
| 99 | MP0004085_abnormal_heartbeat | 0.92972724 |
| 100 | MP0003787_abnormal_imprinting | 0.91531128 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.90424266 |
| 102 | MP0002572_abnormal_emotion/affect_behav | 0.89845034 |
| 103 | MP0001881_abnormal_mammary_gland | 0.89828302 |
| 104 | MP0005365_abnormal_bile_salt | 0.88338329 |
| 105 | MP0002653_abnormal_ependyma_morphology | 0.87907696 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.87694608 |
| 107 | MP0004924_abnormal_behavior | 0.87476083 |
| 108 | MP0005386_behavior/neurological_phenoty | 0.87476083 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.86788407 |
| 110 | MP0001529_abnormal_vocalization | 0.84946495 |
| 111 | MP0001970_abnormal_pain_threshold | 0.84894838 |
| 112 | MP0002160_abnormal_reproductive_system | 0.83923235 |
| 113 | MP0002822_catalepsy | 0.82964420 |
| 114 | MP0002928_abnormal_bile_duct | 0.82622108 |
| 115 | MP0005389_reproductive_system_phenotype | 0.82596060 |
| 116 | MP0004147_increased_porphyrin_level | 0.80761472 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.80686991 |
| 118 | MP0008995_early_reproductive_senescence | 0.80258160 |
| 119 | MP0004484_altered_response_of | 0.80134248 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.79391094 |
| 121 | MP0001905_abnormal_dopamine_level | 0.79240170 |
| 122 | MP0002557_abnormal_social/conspecific_i | 0.77408584 |
| 123 | MP0003948_abnormal_gas_homeostasis | 0.77130841 |
| 124 | MP0002106_abnormal_muscle_physiology | 0.76883991 |
| 125 | MP0005164_abnormal_response_to | 0.74959292 |
| 126 | MP0002909_abnormal_adrenal_gland | 0.74199121 |
| 127 | MP0002163_abnormal_gland_morphology | 0.74187818 |
| 128 | MP0002006_tumorigenesis | 0.73565842 |
| 129 | MP0003045_fibrosis | 0.72659870 |
| 130 | MP0002735_abnormal_chemical_nociception | 0.72519979 |
| 131 | MP0003953_abnormal_hormone_level | 0.72297652 |
| 132 | MP0002127_abnormal_cardiovascular_syste | 0.72208911 |
| 133 | MP0005410_abnormal_fertilization | 0.71936261 |
| 134 | MP0009780_abnormal_chondrocyte_physiolo | 0.71470567 |
| 135 | MP0003635_abnormal_synaptic_transmissio | 0.70347847 |
| 136 | MP0006292_abnormal_olfactory_placode | 0.68773853 |
| 137 | MP0004742_abnormal_vestibular_system | 0.68599196 |
| 138 | MP0009643_abnormal_urine_homeostasis | 0.67368407 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.66915996 |
| 140 | MP0002060_abnormal_skin_morphology | 0.66795272 |
| 141 | MP0003279_aneurysm | 0.66707614 |
| 142 | MP0001727_abnormal_embryo_implantation | 0.64955498 |
| 143 | MP0002998_abnormal_bone_remodeling | 0.60483348 |
| 144 | MP0005369_muscle_phenotype | 0.60077656 |
| 145 | MP0002295_abnormal_pulmonary_circulatio | 0.59362447 |
| 146 | MP0005058_abnormal_lysosome_morphology | 0.58980338 |
| 147 | MP0001533_abnormal_skeleton_physiology | 0.57602775 |
| 148 | MP0001764_abnormal_homeostasis | 0.57385577 |
| 149 | MP0000249_abnormal_blood_vessel | 0.57004427 |
| 150 | MP0009763_increased_sensitivity_to | 0.56998794 |
| 151 | MP0001756_abnormal_urination | 0.56428493 |
| 152 | MP0004782_abnormal_surfactant_physiolog | 0.53398560 |
| 153 | MP0005266_abnormal_metabolism | 0.53157279 |
| 154 | MP0001958_emphysema | 0.52659707 |
| 155 | MP0005167_abnormal_blood-brain_barrier | 0.51977965 |
| 156 | MP0005645_abnormal_hypothalamus_physiol | 0.51359151 |
| 157 | MP0002269_muscular_atrophy | 0.50323835 |
| 158 | MP0005595_abnormal_vascular_smooth | 0.48139920 |
| 159 | MP0002168_other_aberrant_phenotype | 0.47471438 |
| 160 | MP0002638_abnormal_pupillary_reflex | 0.46805998 |
| 161 | MP0003137_abnormal_impulse_conducting | 0.45029563 |
| 162 | MP0002108_abnormal_muscle_morphology | 0.44246174 |
| 163 | MP0006035_abnormal_mitochondrial_morpho | 0.44224036 |
| 164 | MP0005376_homeostasis/metabolism_phenot | 0.42935802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.31907682 |
| 2 | Nemaline bodies (HP:0003798) | 6.23028635 |
| 3 | Myoglobinuria (HP:0002913) | 6.06019993 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.99943722 |
| 5 | Abnormality of fatty-acid metabolism (HP:0004359) | 5.81999601 |
| 6 | Hypoglycemic coma (HP:0001325) | 5.75676408 |
| 7 | Oligomenorrhea (HP:0000876) | 5.74886164 |
| 8 | Dicarboxylic aciduria (HP:0003215) | 5.19433944 |
| 9 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 5.19433944 |
| 10 | Rhabdomyolysis (HP:0003201) | 5.16837058 |
| 11 | Increased muscle lipid content (HP:0009058) | 5.01275100 |
| 12 | Acanthosis nigricans (HP:0000956) | 4.99391047 |
| 13 | Hypertriglyceridemia (HP:0002155) | 4.83156634 |
| 14 | Hepatic necrosis (HP:0002605) | 4.53341735 |
| 15 | * Hyperglycinuria (HP:0003108) | 4.36325787 |
| 16 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.30452008 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 4.22664167 |
| 18 | Nausea (HP:0002018) | 4.19021446 |
| 19 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.18714751 |
| 20 | Generalized aminoaciduria (HP:0002909) | 4.18177826 |
| 21 | Difficulty running (HP:0009046) | 4.08397290 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.82798377 |
| 23 | Ketoacidosis (HP:0001993) | 3.81561347 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 3.77458997 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.76096898 |
| 26 | Hyperammonemia (HP:0001987) | 3.73549357 |
| 27 | Pancreatic cysts (HP:0001737) | 3.66511362 |
| 28 | * Abnormality of glycine metabolism (HP:0010895) | 3.55343701 |
| 29 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 3.55343701 |
| 30 | Bone cyst (HP:0012062) | 3.53134702 |
| 31 | Renal cortical cysts (HP:0000803) | 3.48384572 |
| 32 | Ketosis (HP:0001946) | 3.45567338 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 3.31725701 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 3.31725701 |
| 35 | Increased connective tissue (HP:0009025) | 3.28869504 |
| 36 | Congenital stationary night blindness (HP:0007642) | 3.27084573 |
| 37 | Pancreatic fibrosis (HP:0100732) | 3.19287427 |
| 38 | Multiple enchondromatosis (HP:0005701) | 3.18234450 |
| 39 | Distal arthrogryposis (HP:0005684) | 3.17633225 |
| 40 | Exercise-induced myalgia (HP:0003738) | 3.13641026 |
| 41 | Long foot (HP:0001833) | 3.10571805 |
| 42 | Hyperglycinemia (HP:0002154) | 3.10557119 |
| 43 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.10157839 |
| 44 | Abnormality of alanine metabolism (HP:0010916) | 3.10157839 |
| 45 | Hyperalaninemia (HP:0003348) | 3.10157839 |
| 46 | Lipoatrophy (HP:0100578) | 3.05792997 |
| 47 | True hermaphroditism (HP:0010459) | 3.04477751 |
| 48 | Nephronophthisis (HP:0000090) | 2.99883683 |
| 49 | Hepatocellular necrosis (HP:0001404) | 2.97047247 |
| 50 | Facial diplegia (HP:0001349) | 2.91311444 |
| 51 | Acute encephalopathy (HP:0006846) | 2.90426813 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 2.84083902 |
| 53 | Conjunctival hamartoma (HP:0100780) | 2.81426269 |
| 54 | Limb hypertonia (HP:0002509) | 2.78813385 |
| 55 | Muscle stiffness (HP:0003552) | 2.78253351 |
| 56 | Cerebral edema (HP:0002181) | 2.77200697 |
| 57 | Methylmalonic aciduria (HP:0012120) | 2.74771712 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73997214 |
| 59 | Proximal tubulopathy (HP:0000114) | 2.71847287 |
| 60 | Abnormality of glycolysis (HP:0004366) | 2.68670204 |
| 61 | Increased serum pyruvate (HP:0003542) | 2.68670204 |
| 62 | Absent phalangeal crease (HP:0006109) | 2.68555546 |
| 63 | Lactic acidosis (HP:0003128) | 2.66598073 |
| 64 | Type II lissencephaly (HP:0007260) | 2.66209230 |
| 65 | Rimmed vacuoles (HP:0003805) | 2.64794237 |
| 66 | Myopathic facies (HP:0002058) | 2.64162686 |
| 67 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.61632486 |
| 68 | Muscle fiber splitting (HP:0003555) | 2.61624934 |
| 69 | Growth hormone excess (HP:0000845) | 2.58528342 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.56385823 |
| 71 | Insulin resistance (HP:0000855) | 2.55055054 |
| 72 | Palpitations (HP:0001962) | 2.54926569 |
| 73 | Large hands (HP:0001176) | 2.52319716 |
| 74 | Hypoalphalipoproteinemia (HP:0003233) | 2.52168343 |
| 75 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49890593 |
| 76 | Large for gestational age (HP:0001520) | 2.48842347 |
| 77 | Lethargy (HP:0001254) | 2.48400459 |
| 78 | Myotonia (HP:0002486) | 2.45832562 |
| 79 | Acute necrotizing encephalopathy (HP:0006965) | 2.44339734 |
| 80 | Esophageal neoplasm (HP:0100751) | 2.43392897 |
| 81 | Neoplasm of head and neck (HP:0012288) | 2.43392897 |
| 82 | Neonatal death (HP:0003811) | 2.40293572 |
| 83 | Abnormal finger flexion creases (HP:0006143) | 2.38856541 |
| 84 | Abnormality of the calf musculature (HP:0001430) | 2.38156449 |
| 85 | Prenatal maternal abnormality (HP:0002686) | 2.37029581 |
| 86 | Pigmentary retinal degeneration (HP:0001146) | 2.35069087 |
| 87 | EMG: myopathic abnormalities (HP:0003458) | 2.34126500 |
| 88 | Pancreatitis (HP:0001733) | 2.32833503 |
| 89 | Sudden death (HP:0001699) | 2.31125264 |
| 90 | Vomiting (HP:0002013) | 2.30919452 |
| 91 | Dilated cardiomyopathy (HP:0001644) | 2.29317127 |
| 92 | Abnormal drinking behavior (HP:0030082) | 2.28596031 |
| 93 | Polydipsia (HP:0001959) | 2.28596031 |
| 94 | Respiratory failure (HP:0002878) | 2.27445637 |
| 95 | Inability to walk (HP:0002540) | 2.27089959 |
| 96 | Medial flaring of the eyebrow (HP:0010747) | 2.26307945 |
| 97 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.24755530 |
| 98 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.24755530 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 2.24454974 |
| 100 | Methylmalonic acidemia (HP:0002912) | 2.23239907 |
| 101 | Attenuation of retinal blood vessels (HP:0007843) | 2.21992671 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.21688670 |
| 103 | Increased CSF lactate (HP:0002490) | 2.21188235 |
| 104 | Epidermoid cyst (HP:0200040) | 2.19773796 |
| 105 | Progressive macrocephaly (HP:0004481) | 2.18940958 |
| 106 | Tachypnea (HP:0002789) | 2.17422213 |
| 107 | Ventricular tachycardia (HP:0004756) | 2.17348767 |
| 108 | Ulnar deviation of the wrist (HP:0003049) | 2.16860233 |
| 109 | Tubular atrophy (HP:0000092) | 2.16105394 |
| 110 | Hemorrhage of the eye (HP:0011885) | 2.15808935 |
| 111 | Congenital, generalized hypertrichosis (HP:0004540) | 2.15687544 |
| 112 | Progressive inability to walk (HP:0002505) | 2.15363550 |
| 113 | Hyporeflexia of lower limbs (HP:0002600) | 2.14652756 |
| 114 | Cystic liver disease (HP:0006706) | 2.14389483 |
| 115 | Abnormality of serum amino acid levels (HP:0003112) | 2.13988580 |
| 116 | Increased variability in muscle fiber diameter (HP:0003557) | 2.13912300 |
| 117 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13791079 |
| 118 | Tetraparesis (HP:0002273) | 2.12978702 |
| 119 | Hamartoma of the eye (HP:0010568) | 2.11906622 |
| 120 | Round ear (HP:0100830) | 2.11281213 |
| 121 | Hyperventilation (HP:0002883) | 2.11042105 |
| 122 | Pheochromocytoma (HP:0002666) | 2.08712217 |
| 123 | Metabolic acidosis (HP:0001942) | 2.07885440 |
| 124 | Neonatal hypoglycemia (HP:0001998) | 2.07258916 |
| 125 | Complement deficiency (HP:0004431) | 2.06685848 |
| 126 | Neoplasm of the adrenal gland (HP:0100631) | 2.03465959 |
| 127 | Pendular nystagmus (HP:0012043) | 2.03414395 |
| 128 | Autoimmune thrombocytopenia (HP:0001973) | 2.01770177 |
| 129 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01210602 |
| 130 | Toxemia of pregnancy (HP:0100603) | 2.01001320 |
| 131 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00412900 |
| 132 | Mitochondrial inheritance (HP:0001427) | 1.99858750 |
| 133 | Severe muscular hypotonia (HP:0006829) | 1.98918856 |
| 134 | Cerebral hemorrhage (HP:0001342) | 1.98699867 |
| 135 | Decreased central vision (HP:0007663) | 1.97492807 |
| 136 | Broad metatarsal (HP:0001783) | 1.96172183 |
| 137 | Exercise intolerance (HP:0003546) | 1.96122984 |
| 138 | Skin nodule (HP:0200036) | 1.94703799 |
| 139 | Decreased circulating renin level (HP:0003351) | 1.93861056 |
| 140 | Respiratory distress (HP:0002098) | 1.92384085 |
| 141 | Frequent falls (HP:0002359) | 1.92130721 |
| 142 | Hyperkalemia (HP:0002153) | 1.91827483 |
| 143 | Broad-based gait (HP:0002136) | 1.90619943 |
| 144 | Optic disc pallor (HP:0000543) | 1.90094523 |
| 145 | Areflexia of lower limbs (HP:0002522) | 1.89207470 |
| 146 | Furrowed tongue (HP:0000221) | 1.88533678 |
| 147 | Polyuria (HP:0000103) | 1.88313150 |
| 148 | Chronic hepatic failure (HP:0100626) | 1.87395784 |
| 149 | Athetosis (HP:0002305) | 1.87211482 |
| 150 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.87175740 |
| 151 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.86747539 |
| 152 | Neck muscle weakness (HP:0000467) | 1.85611608 |
| 153 | Sclerocornea (HP:0000647) | 1.84954375 |
| 154 | Increased corneal curvature (HP:0100692) | 1.84278158 |
| 155 | Keratoconus (HP:0000563) | 1.84278158 |
| 156 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84157520 |
| 157 | Subcapsular cataract (HP:0000523) | 1.83638871 |
| 158 | Hypokalemia (HP:0002900) | 1.80276440 |
| 159 | Abnormality of the vocal cords (HP:0008777) | 1.79538441 |
| 160 | Right ventricular cardiomyopathy (HP:0011663) | 1.79213688 |
| 161 | Abnormal biliary tract physiology (HP:0012439) | 1.79022855 |
| 162 | Bile duct proliferation (HP:0001408) | 1.79022855 |
| 163 | Generalized muscle weakness (HP:0003324) | 1.77750786 |
| 164 | Hypothermia (HP:0002045) | 1.75267183 |
| 165 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75240592 |
| 166 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74627823 |
| 167 | Increased hepatocellular lipid droplets (HP:0006565) | 1.74298355 |
| 168 | Congenital hepatic fibrosis (HP:0002612) | 1.74022882 |
| 169 | Bundle branch block (HP:0011710) | 1.70492206 |
| 170 | Increased serum lactate (HP:0002151) | 1.68864696 |
| 171 | Abnormality of potassium homeostasis (HP:0011042) | 1.67663233 |
| 172 | Gait imbalance (HP:0002141) | 1.67414015 |
| 173 | Left ventricular hypertrophy (HP:0001712) | 1.66832205 |
| 174 | Lissencephaly (HP:0001339) | 1.66475343 |
| 175 | Chorioretinal atrophy (HP:0000533) | 1.66363369 |
| 176 | Cerebellar dysplasia (HP:0007033) | 1.66046948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 6.02024018 |
| 2 | BCKDK | 5.24177125 |
| 3 | TRIB3 | 5.14649455 |
| 4 | PDK3 | 4.60472817 |
| 5 | PDK4 | 4.60472817 |
| 6 | CAMK1G | 4.15975753 |
| 7 | SIK1 | 3.18027374 |
| 8 | PDK2 | 3.05930421 |
| 9 | ADRBK2 | 2.69207912 |
| 10 | BMPR1B | 2.62217638 |
| 11 | WNK3 | 2.58943365 |
| 12 | MAP4K2 | 2.32362626 |
| 13 | GRK1 | 2.26508171 |
| 14 | LMTK2 | 2.19338996 |
| 15 | PRKAA2 | 2.09743300 |
| 16 | TIE1 | 2.09571717 |
| 17 | TAOK3 | 2.05257697 |
| 18 | TXK | 2.03975132 |
| 19 | OXSR1 | 1.94091766 |
| 20 | WNK4 | 1.88850806 |
| 21 | MST1R | 1.84569995 |
| 22 | ACVR1B | 1.78116381 |
| 23 | TLK1 | 1.74336906 |
| 24 | MAPK13 | 1.71636300 |
| 25 | TTN | 1.66514990 |
| 26 | NUAK1 | 1.64333281 |
| 27 | ERN1 | 1.61983181 |
| 28 | RIPK1 | 1.59022213 |
| 29 | PIK3CG | 1.51988814 |
| 30 | MAP3K4 | 1.49115375 |
| 31 | INSRR | 1.44775890 |
| 32 | TGFBR2 | 1.40477218 |
| 33 | MUSK | 1.37389534 |
| 34 | IRAK3 | 1.37065926 |
| 35 | PKN2 | 1.35566718 |
| 36 | DAPK2 | 1.35187437 |
| 37 | TNIK | 1.31782240 |
| 38 | FGFR3 | 1.29322921 |
| 39 | NME1 | 1.27891625 |
| 40 | CDK9 | 1.27381651 |
| 41 | MYLK | 1.23781191 |
| 42 | MARK1 | 1.20909335 |
| 43 | STK39 | 1.19921115 |
| 44 | MAP2K6 | 1.14887501 |
| 45 | JAK1 | 1.13597102 |
| 46 | PRKAA1 | 1.11287851 |
| 47 | PDPK1 | 1.10224211 |
| 48 | PINK1 | 1.09930790 |
| 49 | PHKG2 | 1.09290719 |
| 50 | PHKG1 | 1.09290719 |
| 51 | PIK3CA | 1.05611716 |
| 52 | NEK9 | 1.05201321 |
| 53 | CASK | 0.94329323 |
| 54 | CDK6 | 0.93904458 |
| 55 | PDK1 | 0.91519886 |
| 56 | PDGFRA | 0.91065576 |
| 57 | MAP2K7 | 0.90397533 |
| 58 | EPHB2 | 0.89395346 |
| 59 | TRIM28 | 0.87983454 |
| 60 | MAP2K1 | 0.86723279 |
| 61 | MAP3K7 | 0.86607832 |
| 62 | PNCK | 0.84358237 |
| 63 | ADRBK1 | 0.84115607 |
| 64 | PAK3 | 0.83875381 |
| 65 | MKNK2 | 0.79730295 |
| 66 | ERBB3 | 0.77958483 |
| 67 | ILK | 0.75799349 |
| 68 | NEK1 | 0.73371190 |
| 69 | PRKACG | 0.73020045 |
| 70 | JAK2 | 0.71932306 |
| 71 | FLT3 | 0.71409343 |
| 72 | MAP2K4 | 0.70653362 |
| 73 | FGFR2 | 0.70489383 |
| 74 | PRKCH | 0.69493914 |
| 75 | DYRK2 | 0.66717865 |
| 76 | FGFR4 | 0.66330791 |
| 77 | EIF2AK2 | 0.66041196 |
| 78 | CAMK2A | 0.64596002 |
| 79 | LATS1 | 0.63291967 |
| 80 | PRKCE | 0.63206640 |
| 81 | PRKCG | 0.62682361 |
| 82 | FRK | 0.62621629 |
| 83 | JAK3 | 0.62510162 |
| 84 | PRKD1 | 0.60443025 |
| 85 | PRKD3 | 0.60059295 |
| 86 | MAP3K6 | 0.58891269 |
| 87 | VRK1 | 0.58867090 |
| 88 | MAP2K3 | 0.57911872 |
| 89 | PRKCQ | 0.56077211 |
| 90 | VRK2 | 0.54632710 |
| 91 | MAPKAPK5 | 0.54075497 |
| 92 | TEC | 0.53130013 |
| 93 | IKBKB | 0.51460946 |
| 94 | IGF1R | 0.50134285 |
| 95 | PLK2 | 0.49860907 |
| 96 | CAMK1 | 0.49617462 |
| 97 | OBSCN | 0.49494531 |
| 98 | MET | 0.49281306 |
| 99 | CDK4 | 0.49064049 |
| 100 | PRKG1 | 0.48784099 |
| 101 | PTK2B | 0.48713249 |
| 102 | CSNK1G2 | 0.48368314 |
| 103 | ABL2 | 0.47751659 |
| 104 | TGFBR1 | 0.47732783 |
| 105 | LIMK1 | 0.47398598 |
| 106 | MAPK11 | 0.47139723 |
| 107 | PRKG2 | 0.47115747 |
| 108 | GSK3A | 0.47033224 |
| 109 | MAPK15 | 0.45409713 |
| 110 | CSNK1G1 | 0.44605202 |
| 111 | TBK1 | 0.44471324 |
| 112 | MAP2K2 | 0.43750893 |
| 113 | DDR2 | 0.43580063 |
| 114 | CDK19 | 0.43448671 |
| 115 | CSNK1G3 | 0.43292502 |
| 116 | EPHB1 | 0.42414712 |
| 117 | TRPM7 | 0.42304495 |
| 118 | MAPK12 | 0.41789689 |
| 119 | MTOR | 0.41214339 |
| 120 | NLK | 0.39233870 |
| 121 | IRAK1 | 0.38882814 |
| 122 | IRAK2 | 0.38248243 |
| 123 | CAMK4 | 0.37740050 |
| 124 | AKT3 | 0.36514891 |
| 125 | KIT | 0.36470488 |
| 126 | BMX | 0.36450204 |
| 127 | CAMKK2 | 0.36183916 |
| 128 | CSNK1A1 | 0.35499177 |
| 129 | TYK2 | 0.35355088 |
| 130 | PDGFRB | 0.34203241 |
| 131 | STK3 | 0.34151238 |
| 132 | CAMK2D | 0.34081944 |
| 133 | STK11 | 0.34017293 |
| 134 | STK16 | 0.33400062 |
| 135 | SGK3 | 0.32901028 |
| 136 | STK24 | 0.32164666 |
| 137 | RPS6KB1 | 0.32141477 |
| 138 | STK38L | 0.32134392 |
| 139 | LATS2 | 0.31496381 |
| 140 | CAMK2G | 0.31401651 |
| 141 | BCR | 0.31090710 |
| 142 | EPHA3 | 0.31082087 |
| 143 | PLK4 | 0.30304876 |
| 144 | MAP3K3 | 0.29569558 |
| 145 | RPS6KA5 | 0.29536897 |
| 146 | INSR | 0.29004070 |
| 147 | PRKACB | 0.28780917 |
| 148 | CSNK1A1L | 0.27850379 |
| 149 | CSK | 0.27349295 |
| 150 | PRKCA | 0.27250302 |
| 151 | RET | 0.26679936 |
| 152 | RPS6KA6 | 0.26150261 |
| 153 | NME2 | 0.25908935 |
| 154 | AKT1 | 0.24548891 |
| 155 | CCNB1 | 0.24373034 |
| 156 | EIF2AK3 | 0.24261486 |
| 157 | RPS6KC1 | 0.24122075 |
| 158 | RPS6KL1 | 0.24122075 |
| 159 | NTRK3 | 0.23897102 |
| 160 | BRSK2 | 0.23714064 |
| 161 | TNK2 | 0.23628451 |
| 162 | MAP3K14 | 0.22806825 |
| 163 | CSNK1D | 0.22575778 |
| 164 | ABL1 | 0.22574772 |
| 165 | SGK2 | 0.21999870 |
| 166 | DMPK | 0.21534426 |
| 167 | ZAK | 0.19999510 |
| 168 | SRC | 0.19522834 |
| 169 | MAPK4 | 0.19409502 |
| 170 | KDR | 0.18161082 |
| 171 | PRKACA | 0.17984218 |
| 172 | PKN1 | 0.15707176 |
| 173 | MAPKAPK3 | 0.15517210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.88203536 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 5.50370676 |
| 3 | Fatty acid metabolism_Homo sapiens_hsa01212 | 4.20762181 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 4.09614956 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.04816498 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 4.02268895 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.92897988 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.48813863 |
| 9 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 3.08196306 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.64147560 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.59823106 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.46165507 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.36725529 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.28215287 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26872845 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.23622503 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.13267048 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86935036 |
| 19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.79158638 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.76158429 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.67703988 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65980499 |
| 23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.65280586 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.58129522 |
| 25 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.51287111 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.50556521 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.48672209 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.47785385 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.45475517 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44503822 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.42479510 |
| 32 | RNA polymerase_Homo sapiens_hsa03020 | 1.36396466 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.31856778 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29096438 |
| 35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.24927334 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24898501 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.23645046 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.23509172 |
| 39 | Insulin resistance_Homo sapiens_hsa04931 | 1.14269547 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11986083 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11442192 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07880266 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.05553965 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04173416 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03422988 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.02406990 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 1.02356786 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01892854 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00513018 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99778883 |
| 51 | Taste transduction_Homo sapiens_hsa04742 | 0.99778713 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98663332 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.97121891 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.96701244 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91577815 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.91179114 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88339070 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85282512 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81006271 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80915739 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.80068587 |
| 62 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80003481 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78851883 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.76235696 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76196033 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73864914 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72767222 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72560173 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72242177 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71645035 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70182422 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70147553 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69890885 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68648388 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.67104776 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.66114425 |
| 77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.66053042 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65683224 |
| 79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62931367 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61898128 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61544941 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.60624520 |
| 83 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59583014 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59097074 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58763965 |
| 86 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.58434206 |
| 87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58386016 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58137497 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57920204 |
| 90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57796873 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54630794 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54417875 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53667639 |
| 94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52724698 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50833571 |
| 96 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49297893 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.48635335 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.47994932 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47850800 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46823568 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46778928 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45786096 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42485066 |
| 104 | Long-term depression_Homo sapiens_hsa04730 | 0.42419050 |
| 105 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41823988 |
| 106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41522002 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40043260 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37906879 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37552210 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37343580 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32717538 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32122280 |
| 113 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31177852 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30216701 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.29036658 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.25293711 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25121986 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.24678927 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24607822 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22874851 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21420643 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18577052 |
| 123 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18572012 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.17332192 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17281010 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15775960 |
| 127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.13975839 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.13695559 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13488151 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13372853 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12924380 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.12286244 |
| 133 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.11365117 |
| 134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.11162112 |
| 135 | Malaria_Homo sapiens_hsa05144 | 0.11132138 |
| 136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.07584786 |
| 137 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06966352 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.06345762 |
| 139 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.05764508 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.05727431 |
| 141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.05542142 |
| 142 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.04610246 |
| 143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.04454109 |
| 144 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.03729852 |
| 145 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.03373588 |
| 146 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.03318389 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.03088948 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.02875326 |
| 149 | Legionellosis_Homo sapiens_hsa05134 | 0.02606251 |
| 150 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.01515742 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01266095 |
| 152 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.00530279 |
| 153 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.00182653 |
| 154 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0263523 |
| 155 | Salivary secretion_Homo sapiens_hsa04970 | -0.0245913 |

